These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2165009)

  • 61. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Neurosci Lett; 1988 Mar; 86(1):109-13. PubMed ID: 2896322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The cholinergic system in Alzheimer's disease.
    Kása P; Rakonczay Z; Gulya K
    Prog Neurobiol; 1997 Aug; 52(6):511-35. PubMed ID: 9316159
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy.
    Bissette G; Seidler FJ; Nemeroff CB; Slotkin TA
    Ann N Y Acad Sci; 1996 Jan; 777():197-204. PubMed ID: 8624084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The 12th J. A. F. Stevenson memorial lecture. Aging, Alzheimer's disease, and the cholinergic system.
    McGeer PL
    Can J Physiol Pharmacol; 1984 Jul; 62(7):741-54. PubMed ID: 6149804
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The place of choline acetyltransferase activity measurement in the "cholinergic hypothesis" of neurodegenerative diseases.
    Contestabile A; Ciani E; Contestabile A
    Neurochem Res; 2008 Feb; 33(2):318-27. PubMed ID: 17940885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glutamate transmission and toxicity in Alzheimer's disease.
    Greenamyre JT; Maragos WF; Albin RL; Penney JB; Young AB
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):421-30. PubMed ID: 2900537
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits?
    King RG
    Med Hypotheses; 1984 Jul; 14(3):301-6. PubMed ID: 6472159
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?
    Lawlor BA; Davis KL
    Biol Psychiatry; 1992 Feb; 31(4):337-50. PubMed ID: 1348429
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selectivity of excitotoxic mechanisms in Alzheimer's disease.
    May PC
    Neurobiol Aging; 1989; 10(5):606-8; discussion 618-20. PubMed ID: 2572984
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.
    Lowe SL; Bowen DM; Francis PT; Neary D
    Neuroscience; 1990; 38(3):571-7. PubMed ID: 1980143
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Animal models of Alzheimer's disease: glutamatergic denervation as an alternative approach to cholinergic denervation.
    Myhrer T
    Neurosci Biobehav Rev; 1993; 17(2):195-202. PubMed ID: 8515902
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurochemical alterations in Rett syndrome.
    Wenk GL; O'Leary M; Nemeroff CB; Bissette G; Moser H; Naidu S
    Brain Res Dev Brain Res; 1993 Jul; 74(1):67-72. PubMed ID: 8403377
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.
    Procter AW; Palmer AM; Francis PT; Lowe SL; Neary D; Murphy E; Doshi R; Bowen DM
    J Neurochem; 1988 Mar; 50(3):790-802. PubMed ID: 3339353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glutamatergic neurotransmission in Alzheimer's disease.
    Cowburn RF; Hardy JA; Roberts PJ
    Biochem Soc Trans; 1990 Jun; 18(3):390-2. PubMed ID: 2164981
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.
    Reisine TD; Yamamura HI; Bird ED; Spokes E; Enna SJ
    Brain Res; 1978 Dec; 159(2):477-81. PubMed ID: 215272
    [No Abstract]   [Full Text] [Related]  

  • 76. Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells?
    Hertz L
    Brain Res Brain Res Rev; 1989; 14(4):335-53. PubMed ID: 2696574
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Topographical distribution of neurochemical changes in Alzheimer's disease.
    Procter AW; Lowe SL; Palmer AM; Francis PT; Esiri MM; Stratmann GC; Najlerahim A; Patel AJ; Hunt A; Bowen DM
    J Neurol Sci; 1988 Apr; 84(2-3):125-40. PubMed ID: 2898011
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cholinergic function and intellectual decline in Alzheimer's disease.
    Collerton D
    Neuroscience; 1986 Sep; 19(1):1-28. PubMed ID: 3537837
    [No Abstract]   [Full Text] [Related]  

  • 79. Alzheimer's disease: a disorder of cortical cholinergic innervation.
    Coyle JT; Price DL; DeLong MR
    Science; 1983 Mar; 219(4589):1184-90. PubMed ID: 6338589
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neuroplasticity and the progression of Alzheimer's disease.
    Horwitz B
    Int J Neurosci; 1988 Jul; 41(1-2):1-14. PubMed ID: 3045037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.